Issue 12

What’s Next in Biopharma After BIO 2024?

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

SPONSORED STORY

Alcami, the CDMO headquartered in North Carolina, has over 40 years of experience advancing products through every stage of the development lifecycle. They have some excellent new content from across their business units, including:

FEATURED STORIES

Simtra Commences Work on Bloomington Facility Expansion

Read more here.

Thermo Fisher Scientific Unveils CO2 Cell Therapy Incubators for Automated Labs

Read more here.

FTC Supports Rule Change to Expose Anticompetitive Drug Patent Deals

Read more here.

Global Sterile Injectable CDMO Market to Hit $33.7 Billion by 2034

Read more here.

BIO 2024: Adapting Payment Models for Gene Therapy

Read more here.

WuXi Shares Surge Following BIOSECURE Act's Exclusion

Read more here.

SCHOTT Pharma Opens Production Facility in Hungary 

Read more here.